Scientific Sessions 2025  /  Cardiovascular Precision Therapy is at the Bedside  /  Gene Therapy for Heart Failure: From Bench to Bedside
Logo

American Heart Association

  36
  0

Final ID:

Gene Therapy for Heart Failure: From Bench to Bedside

  • Hajjar, Roger  ( Massachusetts General Brigham , Cambridge , Massachusetts , United States )
  • Rossano, Joseph  ( Children's Hospital of Philadelphia , Bryn Mawr , Pennsylvania , United States )
    • Author Disclosures:
    Roger Hajjar: DO have relevant financial relationships ; Ownership Interest:AskBio:Past (completed) ; Advisor:Atamayo:Active (exists now) ; Advisor:Longeveron:Active (exists now) ; Ownership Interest:Medera:Active (exists now) | Joseph Rossano: DO have relevant financial relationships ; Consultant:AskBIo:Active (exists now) ; Consultant:CRI Biotech:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Astellas:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiovascular Precision Therapy is at the Bedside

Monday, 11/10/2025 , 03:15PM - 04:30PM

Main Event

More abstracts on this topic:
Gene Therapy at the Bedside: What Clinicians Need to Know

Helms Adam, Judge Daniel, Parikh Victoria

Navigating the Gene Therapy Frontier: Risks, Rewards, and Patient Safety

Mcnally Elizabeth, Rossano Joseph

More abstracts from these authors:
The basics of pediatric HCM: Who, what, when, where, why?

Rossano Joseph

Gene Therapies for Cardiac and Muscular Diseases

Mcnally Elizabeth, Adler Eric, Hajjar Roger

You have to be authorized to contact abstract author. Please, Login
Not Available